{"id":"W4410578058","doi":"10.1016/j.ijgc.2025.101935","title":"Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; GlaxoSmithKline (Canada); McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Carboplatin; Paclitaxel; Oncology; Toxicity; Endometrial cancer; Internal medicine; Cancer; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003042163,0.0003851887,0.001678255,0.0003200974,0.0001590615,0.0006461605,0.0003092581,0.0004159476,0.001478023],"category_scores_gemma":[0.002851106,0.0002279368,0.002696621,0.0004496707,0.0003104355,0.0003445561,0.0003149147,0.0008422121,0.0001368302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005859117,"about_ca_system_score_gemma":0.0005419959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005366632,"about_ca_topic_score_gemma":0.00078574,"domain_scores_codex":[0.9987195,0.000718866,0.0001276322,0.0001838994,0.0001473969,0.0001027809],"domain_scores_gemma":[0.9983268,0.0004073586,0.0007849302,0.0001075939,0.00008226433,0.000290924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.831411,0.002520324,0.08053572,0.000879566,0.01075988,0.0000897366,0.0001197051,0.002276988,0.006459631,0.00009749998,0.0009241065,0.06392583],"study_design_scores_gemma":[0.2566773,0.2618941,0.4570939,0.0001569118,0.01212024,0.0005410435,0.0001131217,0.005742239,0.003030723,0.00041646,0.002136564,0.00007736816],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992731,0.005604917,0.0003402085,0.0001437692,0.0000714716,0.0001741104,0.0004228449,0.00001202942,0.0004995861],"genre_scores_gemma":[0.9985128,0.0005774356,0.0002228607,0.00008428486,0.00003678146,0.0001115535,0.0003247289,0.000002498741,0.0001270998],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003042163,"threshold_uncertainty_score":0.01608866,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0344239302774716,"score_gpt":0.3686556448096927,"score_spread":0.3342317145322211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}